Concepedia

Sanjay De Mel

SD

Statistics

Publications

25

Citations

787

H-Index

16

Active since

2006

Affiliations

National University Cancer Institute, Singapore(Current)

National University Health System

National University of Singapore

National University Hospital

National Cancer Centre Singapore

Sanjay De Mel is an author at National University Cancer Institute, Singapore specializing in medicine, oncology, and lymphoid neoplasms.

ORCID

Publications per year

2006–2024

25

Publications

25

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Ömer An, Tae‐Hoon Chung, Jing Yuan Chooi et al. · Blood · 2018 · 106 citations · Full text

, , +14

Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Cho Mar Myint Wai, Shangying Chen, The Phyu et al. · Haematologica · 2022 · 82 citations · Full text

, , +15

Pharmacological inhibitors of NF-κB accelerate apoptosis in chronic lymphocytic leukaemia cells

Becky M. Pickering, Sanjay De Mel, M Lee et al. · Oncogene · 2006 · 71 citations

, , +16

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

Katharine L. Lewis, Lasse Hjort Jakobsen, Diego Villa et al. · Journal of Clinical Oncology · 2023 · 47 citations · Full text

, , +16

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma

Min Liu, Giorgio Bertolazzi, Shruti Sridhar et al. · Nature Communications · 2024 · 45 citations · Full text

, , +17

1–5 of 25